Early Antithrombotic Therapy for Aortic Valve Bioprostheses: Is There an Indication for Routine Use? W.R. Eric Jamieson, MD, Susan D. Moffatt-Bruce, MD, Peter Skarsgard, MD, Majdi Abdel Hadi, MD, Jian Ye, MD, Guy J. Fradet, MD, James G. Abel, MD, Michael T. Janusz, MD, Anson Cheung, MD, Eva Germann, MS The Annals of Thoracic Surgery Volume 83, Issue 2, Pages 549-557 (February 2007) DOI: 10.1016/j.athoracsur.2006.07.041 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Medications at discharge for the overall population and individual valve subsets. (p = 0.000001; gray shaded bar = none; black bar = AP only; white bar = AC or AC + AP; AC = anticoagulant; AP = antiplatelet; CE-P = Carpentier-Edwards PERIMOUNT; CE-SAV = Carpentier Edwards SAV; MM = Medtronic Mosaic.) The Annals of Thoracic Surgery 2007 83, 549-557DOI: (10.1016/j.athoracsur.2006.07.041) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions